CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Verapamil

维拉帕米 杂质对照品Verapamil Impurities

EP47 个杂质条目47 impurity entries

本页汇总 维拉帕米 的 47 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 47 impurity reference standards of Verapamil with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 维拉帕米(Verapamil)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesThermal analysis applied to verapamil hydrochloride characterization in pharmaceutical formulations
    Molecules (Basel, Switzerland) · 2010 · Yoshida MI et al.  ·  PMID 20428054  ·  DOI
  2. 杂质研究Impurity studiesInstability of KCNE1-D85N that causes long QT syndrome: stabilization by verapamil
    Pacing and clinical electrophysiology : PACE · 2014 · Sakata S et al.  ·  PMID 24499369  ·  DOI
  3. 分析方法Analytical MethodsAnalytical method development and validation for the analysis of verapamil hydrochloride and its related substances by using ultra perfomance liquid chromatography
    Journal of pharmaceutical and biomedical analysis · 2017 · Vijayabaskar S et al.  ·  PMID 28131058  ·  DOI
  4. 分析方法Analytical MethodsDevelopment and validation of a liquid chromatographic method for the determination of related substances in verapamil hydrochloride
    Journal of pharmaceutical and biomedical analysis · 1997 · Valvo L et al.  ·  PMID 9160266  ·  DOI
  5. 分析方法Analytical MethodsDevelopment and validation of RP-HPLC-UV method for simultaneous determination of buparvaquone, atenolol, propranolol, quinidine and verapamil: a tool for the standardization of rat in situ intestinal permeability studies
    Journal of pharmaceutical and biomedical analysis · 2007 · Venkatesh G et al.  ·  PMID 17157469  ·  DOI

维拉帕米 —— 原料药与杂质对照品Verapamil — drug substance & impurities

共 48 个条目(含原料药本体)48 items incl. the drug substance
Verapamil structure
EP原料药 APIAPI
维拉帕米Verapamil
Verapamil
CAS No.52-53-9
Chemical FormulaC27H38N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 1(Verapamil EP Impurity A) structure
EPA
维拉帕米杂质1(维拉帕米EP杂质A)Verapamil Impurity 1(Verapamil EP Impurity A)
Verapamil Impurity 1(Verapamil EP Impurity A)
CAS No.63434-11-7
Chemical FormulaC25H40Cl2N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 2 (Verapamil EP Impurity B Hydrochloride) structure
EPB
维拉帕米杂质2 (维拉帕米EP杂质B 盐酸盐)Verapamil Impurity 2 (Verapamil EP Impurity B Hydrochloride)
Verapamil Impurity 2 (Verapamil EP Impurity B Hydrochloride)
CAS No.13078-76-7
Chemical FormulaC11H17NO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 3(Verapamil EP Impurity C) structure
EPC
维拉帕米杂质3(维拉帕米EP杂质C)Verapamil Impurity 3(Verapamil EP Impurity C)
Verapamil Impurity 3(Verapamil EP Impurity C)
CAS No.51012-67-0
Chemical FormulaC12H20ClNO2
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 4(Verapamil EP Impurity D) structure
EPD
维拉帕米杂质4(维拉帕米EP杂质D)Verapamil Impurity 4(Verapamil EP Impurity D)
Verapamil Impurity 4(Verapamil EP Impurity D)
CAS No.36770-74-8
Chemical FormulaC14H22ClNO2
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 5(Verapamil EP Impurity E) structure
EPE
维拉帕米杂质5(维拉帕米EP杂质E)Verapamil Impurity 5(Verapamil EP Impurity E)
Verapamil Impurity 5(Verapamil EP Impurity E)
CAS No.93-03-8
Chemical FormulaC9H12O3
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 43 (N-Nitroso Verapamil EP Impurity F) (N-Nitroso Verapamil USP Related Compound A Monomer) structure
EPF
维拉帕米杂质43 (N-亚硝基维拉帕米EP杂质F) (N-亚硝基维拉帕米USP相关化合物A 单体)Verapamil Impurity 43 (N-Nitroso Verapamil EP Impurity F) (N-Nitroso Verapamil USP Related Compound A Monomer)
Verapamil Impurity 43 (N-Nitroso Verapamil EP Impurity F) (N-Nitroso Verapamil USP Related Compound A Monomer)
CAS No.3100114-13-1
Chemical FormulaC17H25N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 6 Monomer (Verapamil EP Impurity F Monomer) (Verapamil USP Related Compound A Monomer) structure
EPF
维拉帕米杂质6 单体 (维拉帕米EP杂质F) (维拉帕米USP相关化合物A 单体)Verapamil Impurity 6 Monomer (Verapamil EP Impurity F Monomer) (Verapamil USP Related Compound A Monomer)
Verapamil Impurity 6 Monomer (Verapamil EP Impurity F Monomer) (Verapamil USP Related Compound A Monomer)
CAS No.34245-14-2
Chemical FormulaC17H26N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 6 (Verapamil EP Impurity F Hydrochloride) (Verapamil USP Related Compound A) structure
EPF
维拉帕米杂质6 (维拉帕米EP杂质F 盐酸盐) (维拉帕米USP相关化合物A)Verapamil Impurity 6 (Verapamil EP Impurity F Hydrochloride) (Verapamil USP Related Compound A)
Verapamil Impurity 6 (Verapamil EP Impurity F Hydrochloride) (Verapamil USP Related Compound A)
CAS No.67775-97-7
Chemical FormulaC17H26N2O2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 7(Verapamil EP Impurity G) structure
EPG
维拉帕米杂质7(维拉帕米EP杂质G)Verapamil Impurity 7(Verapamil EP Impurity G)
Verapamil Impurity 7(Verapamil EP Impurity G)
CAS No.120-14-9
Chemical FormulaC9H10O3
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 8 (Verapamil EP Impurity H) structure
EPH
维拉帕米杂质8 (维拉帕米EP杂质H)Verapamil Impurity 8 (Verapamil EP Impurity H)
Verapamil Impurity 8 (Verapamil EP Impurity H)
CAS No.67018-83-1
Chemical FormulaC26H36N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 9(Verapamil EP Impurity I) structure
EPI
维拉帕米杂质9(维拉帕米EP杂质I)Verapamil Impurity 9(Verapamil EP Impurity I)
Verapamil Impurity 9(Verapamil EP Impurity I)
CAS No.1794-55-4
Chemical FormulaC26H37ClN2O4
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 44 (N-Nitroso Verapamil EP Impurity J) (N-Nitroso Desmethyl Verapamil) structure
EPJ
维拉帕米杂质44 (N-亚硝基维拉帕米EP杂质J) (N-亚硝基去甲基维拉帕米)Verapamil Impurity 44 (N-Nitroso Verapamil EP Impurity J) (N-Nitroso Desmethyl Verapamil)
Verapamil Impurity 44 (N-Nitroso Verapamil EP Impurity J) (N-Nitroso Desmethyl Verapamil)
CAS No.3100114-12-0
Chemical FormulaC26H35N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 10 Monomer(Verapamil EP Impurity J Monomer) structure
EPJ
维拉帕米杂质10 单体(维拉帕米EP杂质J 单体)Verapamil Impurity 10 Monomer(Verapamil EP Impurity J Monomer)
Verapamil Impurity 10 Monomer(Verapamil EP Impurity J Monomer)
CAS No.67018-85-3
Chemical FormulaC26H36N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 10(Verapamil EP Impurity J) structure
EPJ
维拉帕米杂质10(维拉帕米EP杂质J)Verapamil Impurity 10(Verapamil EP Impurity J)
Verapamil Impurity 10(Verapamil EP Impurity J)
CAS No.67812-42-4
Chemical FormulaC26H37ClN2O4
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 11(Verapamil EP Impurity K) structure
EPK
维拉帕米杂质11(维拉帕米EP杂质K)Verapamil Impurity 11(Verapamil EP Impurity K)
Verapamil Impurity 11(Verapamil EP Impurity K)
CAS No.20850-49-1
Chemical FormulaC13H17NO2
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 12 (Verapamil EP Impurity L) structure
EPL
维拉帕米杂质12 (维拉帕米EP杂质L)Verapamil Impurity 12 (Verapamil EP Impurity L)
Verapamil Impurity 12 (Verapamil EP Impurity L)
CAS No.14046-55-0
Chemical FormulaC12H16O3
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 13 Hydrochloride (Verapamil EP Impurity M Hydrochloride) structure
EPM
维拉帕米杂质13 盐酸盐 (维拉帕米EP杂质M 盐酸盐)Verapamil Impurity 13 Hydrochloride (Verapamil EP Impurity M Hydrochloride)
Verapamil Impurity 13 Hydrochloride (Verapamil EP Impurity M Hydrochloride)
CAS No.190850-50-1
Chemical FormulaC42H57N3O6·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 14 Hydrochloride (Verapamil EP Impurity N Hydrochloride) structure
EPN
维拉帕米杂质14 盐酸盐 (维拉帕米EP杂质N 盐酸盐)Verapamil Impurity 14 Hydrochloride (Verapamil EP Impurity N Hydrochloride)
Verapamil Impurity 14 Hydrochloride (Verapamil EP Impurity N Hydrochloride)
CAS No.2726492-31-3
Chemical FormulaC33H47N3O4·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 15 (Verapamil EP Impurity O) structure
EPO
维拉帕米杂质15 (维拉帕米EP杂质O)Verapamil Impurity 15 (Verapamil EP Impurity O)
Verapamil Impurity 15 (Verapamil EP Impurity O)
CAS No.959011-16-6
Chemical FormulaC27H38N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 16 (Verapamil EP Impurity P) structure
EPP
维拉帕米杂质16 (维拉帕米EP杂质P)Verapamil Impurity 16 (Verapamil EP Impurity P)
Verapamil Impurity 16 (Verapamil EP Impurity P)
CAS No.2086275-13-8
Chemical FormulaC29H38N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 7-d6 (Verapamil EP Impurity G-d6) structure
EPG-D6
维拉帕米杂质7-d6 (维拉帕米EP杂质G-d6)Verapamil Impurity 7-d6 (Verapamil EP Impurity G-d6)
Verapamil Impurity 7-d6 (Verapamil EP Impurity G-d6)
CAS No.1162658-05-0
Chemical FormulaC9H4D6O3
Purity>95%询价On request
Verapamil Impurity N1 structure
N1
维拉帕米杂质N1Verapamil Impurity N1
Verapamil Impurity N1
CAS No.102201-30-9
Chemical FormulaC16H20N2O2
Purity>95%现货In stock
10mg25mg50mg100mg
Verapamil Impurity 17 structure
17
维拉帕米杂质17Verapamil Impurity 17
Verapamil Impurity 17
CAS No.10133-74-1
Chemical FormulaC17H19NO2
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 18 structure
18
维拉帕米杂质18Verapamil Impurity 18
Verapamil Impurity 18
CAS No.66618-12-0
Chemical FormulaC14H22BrNO2
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 20 structure
20
维拉帕米杂质20Verapamil Impurity 20
Verapamil Impurity 20
CAS No.27339-25-9
Chemical FormulaC16H21NO3
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 22 structure
22
维拉帕米杂质22Verapamil Impurity 22
Verapamil Impurity 22
CAS No.67018-80-8
Chemical FormulaC26H36N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 23 structure
23
维拉帕米杂质23Verapamil Impurity 23
Verapamil Impurity 23
CAS No.77326-93-3
Chemical FormulaC26H36N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 24 structure
24
维拉帕米杂质24Verapamil Impurity 24
Verapamil Impurity 24
CAS No.126883-99-6
Chemical FormulaC32H44N2O10
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 25 structure
25
维拉帕米杂质25Verapamil Impurity 25
Verapamil Impurity 25
CAS No.302825-76-9
Chemical FormulaC35H45N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 26 structure
26
维拉帕米杂质26Verapamil Impurity 26
Verapamil Impurity 26
CAS No.204642-98-8
Chemical FormulaC27H36N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 27 structure
27
维拉帕米杂质27Verapamil Impurity 27
Verapamil Impurity 27
CAS No.114829-62-8
Chemical FormulaC33H42N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 28 structure
28
维拉帕米杂质28Verapamil Impurity 28
Verapamil Impurity 28
CAS No.16662-47-8
Chemical FormulaC28H40N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 29 structure
29
维拉帕米杂质29Verapamil Impurity 29
Verapamil Impurity 29
CAS No.93-02-7
Chemical FormulaC9H10O3
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 30 structure
30
维拉帕米杂质30Verapamil Impurity 30
Verapamil Impurity 30
CAS No.103796-52-7
Chemical FormulaC11H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 31 structure
31
维拉帕米杂质31Verapamil Impurity 31
Verapamil Impurity 31
CAS No.630-20-6
Chemical FormulaC2H2Cl4
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 32 structure
32
维拉帕米杂质32Verapamil Impurity 32
Verapamil Impurity 32
CAS No.594-20-7
Chemical FormulaC3H6Cl2
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 33 structure
33
维拉帕米杂质33Verapamil Impurity 33
Verapamil Impurity 33
CAS No.75-27-4
Chemical FormulaCHBrCl2
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 34 structure
34
维拉帕米杂质34Verapamil Impurity 34
Verapamil Impurity 34
CAS No.124-48-1
Chemical FormulaCHBr2Cl
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 42 structure
42
维拉帕米杂质42Verapamil Impurity 42
Verapamil Impurity 42
CAS No.3036886-78-6
Chemical FormulaC11H16N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 45 (Verapamil R isomer) structure
45
维拉帕米杂质45 (维拉帕米R异构体)Verapamil Impurity 45 (Verapamil R isomer)
Verapamil Impurity 45 (Verapamil R isomer)
CAS No.38321-02-7
Chemical FormulaC27H38N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 46 structure
46
维拉帕米杂质46Verapamil Impurity 46
Verapamil Impurity 46
CAS No.114847-42-6
Chemical FormulaC26H36N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 47 structure
47
维拉帕米杂质47Verapamil Impurity 47
Verapamil Impurity 47
CAS No.31910-93-7
Chemical FormulaC26H36N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 51 structure
51
维拉帕米杂质51Verapamil Impurity 51
Verapamil Impurity 51
CAS No.123861-30-3
Chemical FormulaC27H38N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Verapamil Impurity 9-D7 structure
9-D7
维拉帕米杂质9-D7Verapamil Impurity 9-D7
Verapamil Impurity 9-D7
CAS No.1330173-18-6
Chemical FormulaC26H30D6N2O4·HCl
Purity>95%询价On request
Verapamil Impurity 10-d6 structure
10-D6
维拉帕米杂质10-d6Verapamil Impurity 10-d6
Verapamil Impurity 10-d6
CAS No.1329651-21-9
Chemical FormulaC26H30D6N2O4·HCl
Purity>95%询价On request
Verapamil Impurity 10-d7 structure
10-D7
维拉帕米杂质10-d7Verapamil Impurity 10-d7
Verapamil Impurity 10-d7
CAS No.1216413-74-9
Chemical FormulaC26H28D7N2O4·HCl
Purity>95%询价On request
Verapamil Impurity 19-d4 structure
19-D4
维拉帕米杂质19-d4Verapamil Impurity 19-d4
Verapamil Impurity 19-d4
CAS No.117067-62-6
Chemical FormulaC2HD4ClO
Purity>95%询价On request
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

维拉帕米 —— 研究文献与合成路线Verapamil — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 维拉帕米 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Verapamil. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. The hypertension drug, verapamil, activates Nrf2 by promoting p62-dependent autophagic Keap1 degradation and prevents acetaminophen-induced cytotoxicity
    Lee DH, Park JS, Lee YS, et al. · BMB reports · 2017 · 被引 31cited 31
  2. Verapamil protects against cartilage degradation in osteoarthritis by inhibiting Wnt/β-catenin signaling
    Takamatsu A, Ohkawara B, Ito M, et al. · PloS one · 2014 · 被引 74cited 74
  3. Detection, isolation and characterization of principal synthetic route indicative impurities in verapamil hydrochloride
    Srinivasan V, Sivaramakrishnan H, Karthikeyan B · Scientia pharmaceutica · 2011 · 被引 7cited 7
  4. High-performance liquid chromatographic analysis of verapamil and its application to determination in tablet dosage forms and to drug dissolution studies
    Ozkan Y, Yilmaz N, Ozkan SA, et al. · Farmaco (Societa chimica italiana : 1989) · 2000 · 被引 14cited 14
  5. Determination of verapamil in pharmaceutical formulations using atomic emission spectrometry
    Khalil S, Kelzieh A · Journal of pharmaceutical and biomedical analysis · 2002 · 被引 11cited 11
  6. Spectrophotometric method for the determination of verapamil hydrochloride in pharmaceutical formulations using N-bromosuccinimide as oxidant
    Rahman N, Hejaz Azmi SN · Farmaco (Societa chimica italiana : 1989) · 2004 · 被引 11cited 11

合成与制备工艺专利Synthesis & process patents

  1. A process for the resolution of racemic verapamil
    BERTOLOTTI CHIARA, LUSSANA MASSIMILIANO, PIZZATTI ENRICA, VIGANO' ENRICO, et al. · 公开号 EP2014644EP2014644 · 2009
  2. Verapamil liposome and preparing method thereof
    WEISAN PAN, NING LI, JIN GUAN, XIANG LI, et al. · 公开号 CN101199505CN101199505 · 2008
  3. Method for preparing delayed-release verapamil hydrochloride
    ZHANG YU WU · 公开号 CN1785170CN1785170 · 2006
  4. Dripping pills of verapamil hydrochloride and its preparation
    QIAN JIN, XU JUN, PENG HONG · 公开号 CN1568961CN1568961 · 2005
  5. Verapamil hydrochloric acid drop pill and its preparation method
    QU YUNZHI · 公开号 CN1565437CN1565437 · 2005

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

维拉帕米 杂质谱研究要点Verapamil — impurity profiling notes

下面这些是拿到 维拉帕米 的 48 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 48 impurity entries for Verapamil, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances